Q2 2020 Aldeyra Therapeutics Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Aldeyra Therapeutics Second Quarter 2020 Financial Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to introduce the company's Chief Financial Officer, Mr. Josh Reed -- Mr. Joshua Reed. Thank you. You may begin.
Thank you, and good morning, everyone. On the call with me are Dr. Todd Brady, Aldeyra President and Chief Executive Officer; and David McMullin, our Chief Commercial Officer. Dr. Brady will begin with an overview of our recent highlights and upcoming clinical milestones. I will discuss our second quarter financial results, and then we'll take your questions.
Please note that this morning's conference call contains forward-looking statements regarding future events and the future performance of Aldeyra. Forward-looking statements include statements regarding the timing of planned clinical trial initiations, Aldeyra's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |